ACTIVITY XANTHINE OXIDOREDUCTASE AND OXIDATIVE STRESS IN PLASMA HYPERTENSIVE AND HEART FAILURE PATIENTS ASSOCIATED WITH AGE-RELATED CATARACT

B. Kisić ,
B. Kisić

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

D. Mirić ,
D. Mirić

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

A. Stolić ,
A. Stolić

Institute for Preventive Medicine, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

I. Dragojević ,
I. Dragojević

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

L. Žorić ,
L. Žorić

Clinic for Eye Diseases, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

M. Stanić
M. Stanić

Centre of Medical Biochemistry, Health Centre Kosovska Mitrovica , Kosovska Mitrovica , Kosovo*

Published: 01.01.2010.

Volume 38, Issue 1 (2010)

pp. 7-11;

https://doi.org/10.70949/pramed201001318K

Abstract

Oxidative stress and associated oxidative damage are mediators of vascular injury and inflammation in many cardiovascular diseases, including hypertension, atherosclerosis, ischemic heart disease, diabetes. Xanthine oxidoreductase is one of the enzymes producing free radicals in the cardiovascular system, and it can contribute to the increment of the oxidative stress and, consequently, blood pressure. The xanthine oxidase is a molybdoenzyme capable of catalyzing the oxidation of hypoxanthine and xanthine in the process of purine metabolism. Xanthine oxidase can exist in two interconvertible forms, either as xanthine dehydrogenase or xanthine oxidase. The aim of the paper was investigate the activity xanthine oxidoreductase in the plasma patients with age related cataract, with hypertensive, and with heart failure. Clinical and biochemical researches were carried out in 73 patients with age related cataract, mean age 72±7 years, divided into group with hypertensive (N=35), with heart failure (N=22) and group normotensive and without heart failure (N=16). Plasma xanthine oxidoreductase activity was determined spectrophotometrically by measuring the formation of uric acid from hypoxanthine at 293 nm. The concentration of triglycerides (TG), total cholesterol (TC), LDL-C, HDL-C in plasma were determined. Our findings show a significantly increased activity xanthine oxidoreductase in plasma hypertensive patients (XO 9.18±1.5 U/L) (p< 0.001) and patients with heart failure (XO 10.44±1.53U/L) (p< 0.001), compared with values plasma xanthine oxidoreductase activity in normotensive and patients without heart failure (XOD 6.02±1.4 U/L). Concentrations of plasma TG, TC and LDL-C were elevated in groups with hypertensive and with heart failure, and we to find significant differences with group normotensive and without heart failure values. Elevated activity of plasma xanthine oxidoreductase contribute to the increasåd oxidative stress and may play a role in accelerated atherosclerosis. 

Keywords

References

1.
Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett. 286:152–4.
2.
Yokoyama Y, Beckman JS, Beckman TK, Wheat JK, Cash TG, Freeman BA, et al. Circulating xanthine oxidase: Potential mediator of ischemic injury. Am J Physiol. 258.
3.
Phan SH, Gannon DE, Ward PA, Karmiol S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: Evidence of a role for elastase. Am J Respir Cell Mol Biol. 6:270–8.
4.
Zalba G, San José G, Moreno MU, Fortuño MA, Fortuño A. Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase. Hypertension. 38(6):1395–9.
5.
Vanden H, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 273:18092–8.
6.
Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: Implications in hypertension. Histochem Cell Biol. 122:339–52.
7.
Sau AK, Mondal MS, Mitra S. Interaction of Ca2+ ion with milk xanthine oxidase. Biochim Biophys Acta. 1544:89–95.
8.
Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:801–9.
9.
Pandey NR, Kaur G, Chandra M, Sanwal GG, Misra MK. Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Intern J Cardiol. 76:33–8.
10.
Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM, Forte TM. Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochem Biophys Res Commun. 290:921–7.
11.
Maytin M, Leopold J, Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep. 1:156–64.
12.
Battelli MG, Abbondanza A, Musiani S, Buonamici L, Strocchi P, Tazzari PL, et al. Determination of xanthine oxidase in human serum by a competitive enzyme-linked immunosorbent assay (ELISA. Clin Chim Acta. 281:147–58.
13.
Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine oxidase and extracellular superoxide dismutase. Circulation. 106:3073–8.
14.
Lacy F, O’Connor DT, Schmid-Schoonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 16:291–303.
15.
Herman AG, Moncada S. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur Heart J. 26(19):1945–55.
16.
Harrison R. Structure and function of xanthine oxidoreductase: Where are we now? Free Radic Biol Med. 33(6):774–97.
17.
Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:3527–61.
18.
Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension. 31:162–9.
19.
Chaves FJ, Corella D, Blesa S, Mansego ML, Marín P, Portoles O, et al. Xanthine oxidoreductase polymorphisms: Influence on blood pressure and oxidative stress levels. Pharmacogenet Genomics. 17(8):589–96.
20.
Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res. 87(10):840–4.
21.
Bergmayer UH. Methoden Der Enzymatischen Analyse.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by